nimesulide and anandamide

nimesulide has been researched along with anandamide in 5 studies

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's2 (40.00)24.3611
2020's1 (20.00)2.80

Authors

AuthorsStudies
Alexandre-Moreira, MS; Barreiro, EJ; Bechara, EJ; Bertho, AL; Calixto, JB; De-Paula, FS; Duarte, CD; Dutra, F; Ferreira, J; Fraga, CA; Goulart, MO; Lacerda, DI; Martins, MV; Miranda, AL; Nunes, MP; Tributino, JL1
Alger, BE; Kim, J1
Glaser, ST; Kaczocha, M1
Harvey, BS; Nicotra, LL; Smid, SD; Vu, M1
Martin-Fardon, R; Parsons, LH; Pavon, FJ; Polis, I; Roberto, M; Rodriguez de Fonseca, F; Serrano, A; Stouffer, DG1

Other Studies

5 other study(ies) available for nimesulide and anandamide

ArticleYear
Synthesis, pharmacological evaluation and electrochemical studies of novel 6-nitro-3,4-methylenedioxyphenyl-N-acylhydrazone derivatives: Discovery of LASSBio-881, a new ligand of cannabinoid receptors.
    Bioorganic & medicinal chemistry, 2007, Mar-15, Volume: 15, Issue:6

    Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antioxidants; Arachidonic Acid; Arachidonic Acids; Biphenyl Compounds; Brain; Cannabinoid Receptor Modulators; Carrageenan; Cell Proliferation; Edema; Endocannabinoids; Female; Formaldehyde; Free Radical Scavengers; Hydrazines; Hydrazones; Ligands; Male; Mice; Models, Molecular; Pain; Picrates; Polyunsaturated Alkamides; Pyridines; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Structure-Activity Relationship; Superoxides; T-Lymphocytes

2007
Inhibition of cyclooxygenase-2 potentiates retrograde endocannabinoid effects in hippocampus.
    Nature neuroscience, 2004, Volume: 7, Issue:7

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Cannabinoid Receptor Modulators; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Cyclooxygenase Inhibitors; Drug Synergism; Endocannabinoids; Enzyme Inhibitors; Glycerides; Hippocampus; In Vitro Techniques; Isoenzymes; Male; Meloxicam; Membrane Potentials; Neural Inhibition; Patch-Clamp Techniques; Piperidines; Polyunsaturated Alkamides; Prostaglandin-Endoperoxide Synthases; Pyramidal Cells; Pyrazoles; Rats; Rats, Sprague-Dawley; Sulfonamides; Thiazines; Thiazoles

2004
Cyclooxygenase-2 mediates anandamide metabolism in the mouse brain.
    The Journal of pharmacology and experimental therapeutics, 2010, Volume: 335, Issue:2

    Topics: Amidohydrolases; Animals; Arachidonic Acids; Autoradiography; Biological Availability; Blotting, Western; Cyclooxygenase 2; Cyclooxygenase 2 Inhibitors; Endocannabinoids; Light; Mice; Mice, Inbred C57BL; Polyunsaturated Alkamides; Reverse Transcriptase Polymerase Chain Reaction; Somatosensory Cortex; Substrate Specificity; Sulfonamides; Visual Cortex

2010
Prostaglandin ethanolamides attenuate damage in a human explant colitis model.
    Prostaglandins & other lipid mediators, 2013, Volume: 100-101

    Topics: Adult; Amides; Arachidonic Acids; Bimatoprost; Cloprostenol; Colitis; Colon, Sigmoid; Cyclooxygenase 2; Cyclooxygenase Inhibitors; Dinoprost; Dinoprostone; Endocannabinoids; Female; Humans; Immunohistochemistry; Interleukin-1beta; Male; Middle Aged; Oxazoles; Polyunsaturated Alkamides; Receptors, Prostaglandin; Sulfonamides; Tissue Culture Techniques; Tumor Necrosis Factor-alpha; Young Adult

2013
COX-2 Inhibition Antagonizes Intra-Accumbens 2-Arachidonoylglycerol-Mediated Reduction in Ethanol Self-Administration in Rats.
    Alcoholism, clinical and experimental research, 2020, Volume: 44, Issue:11

    Topics: Alcohol Drinking; Animals; Arachidonic Acids; Biphenyl Compounds; Cyclooxygenase 2 Inhibitors; Dose-Response Relationship, Drug; Endocannabinoids; Glycerides; Male; Nucleus Accumbens; Polyunsaturated Alkamides; Rats; Rats, Wistar; Receptor, Cannabinoid, CB1; Rimonabant; Self Administration; Sulfonamides

2020